Skriber Raises $1.3 Million in Oversubscribed Pre-Seed Round to Advance AI-Powered Clinical Documentation
Skriber, the Salt Lake City–based medical AI scribe startup, has closed an oversubscribed pre-seed funding round, raising $1.3 million to accelerate the growth of its AI-driven clinical documentation platform and expand its reach across healthcare providers. The recently announced financing reflects growing investor confidence in Skriber’s AI technology, which aims to reduce administrative burden on clinicians and streamline patient note-taking.
The funding round was SeedToB Capital and Morgan Creek Capital Management, two investors with strong track records in backing early-stage technology ventures and transformative healthcare solutions. In addition to capital, these lead investors bring strategic guidance and networks that are expected to help Skriber scale faster and more efficiently in the competitive AI healthcare market.
Founded by CEO Hayden Plummer, Skriber’s core product leverages advanced artificial intelligence to automatically capture clinician–patient conversations and generate structured clinical notes in real time. This capability addresses one of the most persistent pain points in healthcare workflows: the time clinicians spend on documentation instead of direct patient care. With the new funding, Skriber plans to invest heavily in research and development to further enhance its platform’s capabilities and expand its team in areas such as product innovation, customer success, and enterprise support.
Skriber’s AI platform has already gained adoption among healthcare providers seeking to combat clinician burnout and improve overall documentation efficiency. The startup differentiates itself with features such as rapid transcription processing, natural language AI assistance, and broad language support, enabling clinicians to work at the pace of real clinical environments while maintaining accuracy and compliance with healthcare documentation standards.
According to company announcements, recent upgrades to the Skriber platform include capabilities such as near-instantaneous documentation processing and enhanced AI tools that allow clinicians to interact with and refine their notes using everyday language. These enhancements have positioned Skriber as a comprehensive solution for healthcare providers looking to modernize clinical documentation without disrupting existing electronic medical record systems.
The oversubscribed nature of the pre-seed round signals strong market demand for solutions that address the administrative challenges faced by medical professionals. Investors participating in the round highlighted Skriber’s potential to reshape clinical workflows by significantly reducing the time clinicians spend on administrative tasks, thereby allowing them to focus more on patient care. The strategic backing from SeedToB Capital and Morgan Creek underscores a broader trend of venture capital interest in early-stage AI companies targeting niche, high-impact use cases in healthcare.
With this injection of capital, Skriber plans to scale its operations, accelerate product development, and support growing enterprise partnerships within the healthcare ecosystem. Expansion efforts will focus on enhancing the platform’s integration with existing healthcare IT systems, as well as broadening its customer base to include larger health systems and independent practices alike. The company also intends to continue building out its team across engineering, sales, and support functions to sustain its rapid growth trajectory.
Beyond product and customer expansion, the funding will support Skriber’s efforts to maintain a competitive edge in a rapidly evolving AI landscape. By investing in continuous innovation and adopting advanced machine learning techniques, the company aims to refine its documentation tools and deliver richer insights to clinicians and healthcare organizations. These efforts align with Skriber’s broader mission to reduce clinician workload, improve documentation accuracy, and enhance overall care delivery.
Skriber’s pre-seed raise comes at a time when the healthcare industry is increasingly turning to artificial intelligence to improve efficiency and care quality. Solutions that can automate routine tasks and provide meaningful support to overburdened clinicians are gaining traction among investors and healthcare leaders alike. With its recent funding milestone and strategic investor support, Skriber is positioned to accelerate its mission and expand its impact across the healthcare sector.
As Skriber moves forward with its growth plans, the startup is expected to play an important role in shaping the future of clinical documentation, leveraging AI to bridge the gap between patient care and administrative demands. With a solid financial foundation and a clear vision for innovation, Skriber’s journey reflects a broader shift toward intelligent, automated solutions that empower healthcare professionals and improve patient outcomes.
